Ardelyx, INC Form 4 insider transactions

Elizabeth Grammer, Chief Legal and Administrative Officer of Ardelyx, Inc., sold 7,089 shares of common stock on August 20, 2024, to cover withholding taxes related to the vesting of restricted stock units.

Robert Ora Felsch, SVP Finance and Chief Accounting Officer of Ardelyx, Inc., sold 3,567 shares of common stock on August 20, 2024, to cover withholding taxes upon the vesting of restricted stock units.

Robert Blanks, Chief Regulatory and Quality Affairs Officer at Ardelvx, sold shares of common stock to cover withholding taxes upon the vesting of restricted stock units.

David Rosenbaum, Chief Development Officer of Ardelvx, reports the sale and acquisition of common stock and derivative securities.

Eric Duane Foster, Chief Commercial Officer of Ardelvx, Inc., reports the acquisition of 180,000 shares of common stock and 230,000 stock options.

Michael Raab, President and CEO of Ardelix, Inc., sold 1,229 shares of common stock at $5.71 per share on August 12, 2024, under a pre-arranged 10b5-1 trading plan.

Ardelix's CEO, Michael Raab, exercised stock options and sold 30,000 shares of common stock at an average price of $5.6438, pursuant to a pre-arranged 10b5-1 trading plan.

Ardelvx CEO Michael Raab sold 7,500 shares of common stock on July 15, 2024, at a weighted average price of $5.969, pursuant to a pre-arranged 10b5-1 trading plan.

Ardelix's CEO, Michael Raab, sold 2,310 shares of common stock at $6.59 per share on June 28, 2024, under a pre-arranged 10b5-1 trading plan.

Robert Blanks, Chief Regulatory and Quality Affairs Officer of Ardelix, Inc., sold 38,000 shares of common stock on June 21, 2024, under a pre-arranged 10b5-1 trading plan.

Director Richard J. Rodgers acquired shares and stock options in Ardelvx, Inc. under the company's Non-Employee Director Compensation Program.

Director Muna Bhanji acquired stock options in Ardelyx, Inc. on June 14, 2024, as part of the Non-Employee Director Compensation Program.

Director William C. Bertrand Jr. acquired 11,023 shares of common stock and options for 40,243 shares of common stock in Ardelvx, Inc. under the company's Non-Employee Director Compensation Program.

Director Onaiza Cadoret-Manier acquired stock options in Ardelix, Inc. on June 14, 2024, as part of the company's Non-Employee Director Compensation Program.

Director Robert B. Bazemore acquired stock options in Ardelix, Inc. on June 14, 2024.

Director David Mott reports acquisition of shares and stock options in Ardelyx, Inc. through a non-employee director compensation program.

Ardelvx CEO Michael Raab exercised stock options and sold 35,000 shares of common stock on June 13, 2024.

Laura A. Williams, Chief Medical Officer of Ardelvx, Inc., reports the exercise of stock options and subsequent sale of shares on June 5, 2024.

Chief Development Officer David P. Rosenbaum of Ardelvx, Inc. reports selling 17,872 shares of common stock at $7 on June 3, 2024.

Ardelvx CEO Michael Raab sold 7,500 shares of common stock on May 29, 2024, at an average price of $6.7187 per share, according to a Form 4 filing with the SEC.

Laura A. Williams, Chief Medical Officer of Ardelyx, Inc., sold shares of common stock to cover withholding taxes upon the vesting of restricted stock units.

David P. Rosenbaum, Chief Development Officer of Ardelyx, Inc., sold shares of common stock to cover withholding taxes upon the vesting of restricted stock units.

Susan Rodriguez, Chief Commercial Officer of Ardelyx, Inc., sold 6,703 shares of common stock to cover withholding taxes upon the vesting of restricted stock units.

Ardelyx's Chief Financial Officer, Justin Renz, sold 5,167 shares of common stock on May 21, 2024, to cover withholding taxes related to the vesting of restricted stock units.

Michael Raab, CEO of Ardelyx, Inc., reports the sale of shares to cover withholding taxes upon the vesting of restricted stock units, along with adjustments to beneficial ownership.

Elizabeth Grammer, Chief Legal and Administrative Officer of Ardelyx, Inc., reports selling shares to cover withholding taxes upon vesting of restricted stock units.

Robert Ora Felsch, SVP Finance and Chief Accounting Officer at Ardelyx, Inc., sold shares to cover withholding taxes upon the vesting of restricted stock units.

Robert Blanks, Chief Regulatory and Quality Affairs Officer at Ardelvx, sold 4,855 shares of common stock to cover withholding taxes upon the vesting of restricted stock units.

Ardelix CEO Michael Raab sold 3,000 shares of common stock at $7.99 per share on May 14, 2024, under a pre-arranged 10b5-1 trading plan.

Robert Felsch, SVP Finance and Chief Accounting Officer of Ardelvx, Inc., reports the acquisition and disposal of common stock and stock options.